Continuous Bladder Irrigation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Foley 3 Way Catheters(Silicone Catheters, Latex Catheters), Irrigation Bags, Accessories (Irrigation Set, Roller Clamp, Outlet Bags)), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.49 Billion
CAGR (2026-2031)	4.23%
Fastest Growing Segment	Foley 3 Way Catheters
Largest Market	North America
Market Size (2031)	USD 1.91 Billion

Market Overview

The Global Continuous Bladder Irrigation Devices Market will grow from USD 1.49 Billion in 2025 to USD 1.91 Billion by 2031 at a 4.23% CAGR. Continuous bladder irrigation devices are specialized medical systems designed to facilitate the uninterrupted flow of sterile saline into the bladder, primarily to prevent clot retention and maintain catheter patency following urological surgeries such as Transurethral Resection of the Prostate. The market is fundamentally driven by the escalating global prevalence of urological disorders, including Benign Prostatic Hyperplasia, which necessitates frequent surgical interventions. Additionally, the expanding geriatric population serves as a primary catalyst for growth, as this demographic is disproportionately susceptible to conditions requiring postoperative irrigation to ensure successful recovery and minimize complications.

The demand for these clinical solutions is substantially supported by recent data regarding disease incidence. According to the American Cancer Society, in 2024, an estimated 83,190 new cases of bladder cancer were projected to be diagnosed in the United States, underscoring the critical necessity for effective postoperative management tools. Despite these strong growth indicators, the market faces a significant impediment regarding the risk of catheter-associated urinary tract infections. The stringent requirements for infection control and the potential for hospital-acquired complications remain a substantial challenge that can limit the prolonged utilization of these devices in healthcare settings.

Key Market Drivers

The rapid expansion of the geriatric population serves as a critical determinant for the market, primarily due to the high correlation between advanced age and Benign Prostatic Hyperplasia (BPH). As the male population ages, the incidence of prostate enlargement rises significantly, necessitating surgical interventions like Transurethral Resection of the Prostate (TURP) where continuous bladder irrigation is mandatory to prevent hematuria-related complications and ensure catheter patency. This demographic inevitability ensures a consistent baseline demand for irrigation systems to manage postoperative recovery in aging patients. According to AUANews, July 2024, in the 'Status of the Society of Benign Prostatic Disease in 2024' article, Benign Prostatic Hyperplasia impacts around 60% of men in their 60s and nearly every man in his 80s and beyond, creating a substantial and growing patient pool requiring effective urological management.

Concurrently, the market is propelled by the increasing volume of urological procedures, driven by improved diagnostic rates and the clearance of surgical backlogs post-pandemic. The surge in surgical throughput for conditions such as bladder cancer and prostate disorders directly amplifies the daily consumption of irrigation fluids and associated catheter systems in hospital settings. For instance, according to Prostate Cancer UK, April 2024, in the 'Prostate cancer referrals during and after the pandemic' report, the number of patients treated for urological cancer in England increased to 67,142 between March 2022 and February 2023, representing an 8.5% rise compared to the pre-pandemic baseline. This escalating procedural activity translates into tangible revenue expansion for device manufacturers. Illustrating this commercial momentum, according to Coloplast, in 2024, the company's Interventional Urology business area delivered an organic growth of 5% for the financial year, driven by sustained demand in endourology and men's health segments.

Download Free Sample Report

Key Market Challenges

The primary impediment hampering the growth of the Global Continuous Bladder Irrigation Devices Market is the persistent risk of catheter-associated urinary tract infections (CAUTIs). Since continuous irrigation relies on indwelling catheters, the prolonged use of these systems creates a direct pathway for bacterial colonization, significantly increasing patient vulnerability. In response, healthcare institutions are rigorously enforcing "catheter-off" protocols and antibiotic stewardship programs that mandate the early removal of urological devices. This shift in clinical practice directly restricts the duration of irrigation therapy, thereby reducing the consumption volume of disposable irrigation sets and sterile fluids, which negatively impacts the recurring revenue streams for manufacturers.

Furthermore, the economic burden of treating hospital-acquired conditions forces medical administrators to limit the utilization of invasive technologies. Hospitals often face non-reimbursement penalties for preventable infections, making the extended use of irrigation devices a financial liability. According to the Association for Professionals in Infection Control and Epidemiology, in 2024, catheter-associated urinary tract infections accounted for more than 30% of all healthcare-associated infections. This high prevalence rate compels providers to minimize device dependence to avoid the substantial costs associated with infection management, consequently stunting market expansion.

Key Market Trends

The Integration of Smart Sensors for Real-Time Flow Monitoring is significantly advancing the Global Continuous Bladder Irrigation Devices Market by addressing the critical need for precise fluid management and automated clot detection. Advanced sensor-based devices are now capable of continuously analyzing outflow characteristics, such as color and volume, to automatically adjust irrigation rates, thereby mitigating the risks of catheter obstruction and bladder overdistension. This technological evolution directly enhances clinical outcomes by reducing the complications associated with subjective manual regulation errors. For instance, according to the Urology Journal, October 2024, in the study 'Efficacy and Safety of a Self-Improved Continuous Bladder Irrigation Sensor Device', patients treated with the sensor-integrated system demonstrated a significantly shorter hospital stay of 3.3 days compared to 3.6 days for those receiving standard manual care, highlighting the efficiency and safety benefits of these intelligent systems.

Concurrently, there is a prominent Rising Utilization of Single-Use and Disposable Irrigation Sets, driven by stringent infection control protocols and the push for operational efficiency in urological care. Healthcare facilities are increasingly transitioning to fully disposable systems to eliminate the cross-contamination risks inherent in reusable components and to streamline postoperative workflows by removing the need for complex reprocessing logistics. This industry-wide shift toward disposable solutions is reflected in the robust performance of key market segments focused on single-use innovations. According to Ambu A/S, November 2024, in the 'Annual Report 2023/24', the company's Endoscopy Solutions business, which encompasses single-use urology devices, achieved an organic revenue growth of 19.7%, signaling a strong and sustained market demand for disposable interventional technologies.

Segmental Insights

The Foley 3 Way Catheters segment is identified as the fastest-growing category in the Global Continuous Bladder Irrigation Devices Market. This growth is principally attributed to the increasing incidence of urological conditions, particularly among aging populations, which necessitates frequent prostate surgeries. These catheters are critical for simultaneous fluid delivery and drainage, a function required to prevent obstruction from blood clots during post-operative care. Additionally, the segment benefits from the clinical preference for devices that support effective fluid management strategies, thereby ensuring patient safety and minimizing hospital recovery times within the healthcare sector.

Regional Insights

North America holds a dominant position in the global continuous bladder irrigation devices market, driven by the high prevalence of urological conditions such as benign prostatic hyperplasia and bladder cancer. This leadership is supported by a well-established healthcare infrastructure that encourages early diagnosis and treatment. Additionally, supportive reimbursement frameworks and clear regulatory guidelines from the U.S. Food and Drug Administration facilitate the efficient approval and adoption of these medical devices. Consequently, the combination of rising clinical demand and favorable healthcare policies sustains the region’s market prominence.

Recent Developments

• In December 2025, UMED Inc. announced that its UroRinse Light system was named a CES 2026 Innovation Awards Honoree in the Digital Health category. The company described the device as the world's first system designed to fully automate and standardize bladder irrigation for patients with long-term urinary catheters. This sensor-based technology features automated inflow and outflow control, a closed-system design to minimize contamination risks, and the ability to deliver consistent irrigation cycles. The system aims to address complications such as catheter-associated urinary tract infections and allows for safe use in both hospital and home care settings.
• In November 2025, Cardinal Health completed its acquisition of Solaris Health, a leading urology management services organization, for approximately $1.9 billion. This strategic transaction integrated more than 750 providers across over 250 locations into the company's multi-specialty platform, The Specialty Alliance. The acquisition significantly scaled the company's Urology Alliance, strengthening its ability to support community-based urology practices and deliver integrated specialty care. Management at Cardinal Health stated that the move aligned with their broader strategy to expand in high-growth specialty areas, including urology, oncology, and autoimmune diseases.
• In January 2025, UNOQUIP GmbH, a Switzerland-based medical device manufacturer, launched a new range of postoperative catheter solutions specifically designed for the Global Continuous Bladder Irrigation Devices Market. The new product line includes the Hematuria Management Catheter and the 3-Way Silicone Foley Catheter, both engineered to facilitate effective continuous irrigation following urological surgeries. These devices feature specialized designs to address clinical challenges such as clot retention and to ensure efficient bladder drainage. The launch aimed to enhance patient safety and comfort while expanding the company's portfolio of urological care products for global healthcare providers.
• In August 2024, Teleflex Medical, Inc. received FDA clearance for its Rüsch Latex Gold Foley Catheter, a device indicated for patients requiring routine bladder drainage and continuous bladder irrigation. The regulatory approval covered the 3-Way Latex Foley Catheters, which are designed with a cylindrical tip and multiple eyes to facilitate simultaneous irrigation and drainage, a critical function for post-operative urological care. This clearance confirmed that the device met the necessary safety and performance standards for prescription use in clinical settings. The approval underscored the company's ongoing commitment to maintaining a robust portfolio of essential urological devices.

Key Market Players

• Sterimed Group
• Angiplast pvt. ltd.
• Advin Health Care
• AdvaCare Pharma
• Teleflex Incorporated
• BACTIGUARD AB
• VOGT MEDICAL
• C. R. Bard
• Coloplast Corp
• Hospital Equipment Manufacturing Company
• Baxter Internationals

By Product	By End user	By Region
Foley 3 Way Catheters(Silicone Catheters, Latex Catheters) Irrigation Bags Accessories (Irrigation Set, Roller Clamp, Outlet Bags)	Hospitals & Clinics Ambulatory Care Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Continuous Bladder Irrigation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Continuous Bladder Irrigation Devices Market, By Product:

• Foley 3 Way Catheters(Silicone Catheters, Latex Catheters)
• Irrigation Bags
• Accessories (Irrigation Set, Roller Clamp, Outlet Bags)

• Continuous Bladder Irrigation Devices Market, By End user:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

• Continuous Bladder Irrigation Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE